S100A9 and myelodysplastic syndrome: Cytotoxicity was higher in lower-risk MDS-lymphocytes than in high-risk MDS-lymphocytes, and S100a9 partially rescued the exhausted cytotoxicity in lymphocytes (Figure 2A).